Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/44706
Title: | Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain |
Author: | Cristobal, Ignacio Febrer, Laia Crespo, Carlos Arbat, Agnès Hernandez, Francisco J. Brosa, Max |
Keywords: | Ginecologia Anàlisi econòmica Espanya Gynecology Economic analysis Spain |
Issue Date: | 2011 |
Publisher: | Elsevier B.V. |
Abstract: | To compare the cost and effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) versus combined oral contraception (COC) and progestogens (PROG) in first-line treatment of dysfunctional uterine bleeding (DUB) in Spain. STUDY DESIGN: A cost-effectiveness and cost-utility analysis of LNG-IUS, COC and PROG was carried out using a Markov model based on clinical data from the literature and expert opinion. The population studied were women with a previous diagnosis of idiopathic heavy menstrual bleeding. The analysis was performed from the National Health System perspective, discounting both costs and future effects at 3%. In addition, a sensitivity analysis (univariate and probabilistic) was conducted. RESULTS: The results show that the greater efficacy of LNG-IUS translates into a gain of 1.92 and 3.89 symptom-free months (SFM) after six months of treatment versus COC and PROG, respectively (which represents an increase of 33% and 60% of symptom-free time). Regarding costs, LNG-IUS produces savings of 174.2-309.95 and 230.54-577.61 versus COC and PROG, respectively, after 6 months-5 years. Apart from cost savings and gains in SFM, quality-adjusted life months (QALM) are also favourable to LNG-IUS in all scenarios, with a range of gains between 1 and 2 QALM compared to COC and PROG. CONCLUSIONS: The results indicate that first-line use of the LNG-IUS is the dominant therapeutic option (less costly and more effective) in comparison with first-line use of COC or PROG for the treatment of DUB in Spain. LNG-IUS as first line is also the option that provides greatest health-related quality of life to patients. |
Note: | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.ejogrb.2010.08.019 |
It is part of: | European Journal Of Obstetrics & Gynecology And Reproductive Biology, 2011, vol. 154, num. 1, p. 71-80 |
URI: | http://hdl.handle.net/2445/44706 |
Related resource: | http://dx.doi.org/10.1016/j.ejogrb.2010.08.019 |
ISSN: | 0301-2115 |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
579141.pdf | 584.04 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.